Tempus Labs' Series C Round

Tempus Labs raised a round of funding on September 25, 2017.

Tempus Labs is a personalized medicine technology company that aims to take a data-driven approach to cancer treatment by using machine learning and genomic sequencing to better understand a patient's…

Articles about Tempus Labs' Series C Round: